As known, the first-class mutations included prognostic genes such as CEBPA, FLT3, DNMT3A, NPM1, and RNF213; they are previously observed to correlate with prognosis of AML [28–30]. The gene discussed is FLT3; the disease is acute myeloid leukemia.